Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 5
Submit an article Journal homepage
71
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia

Emanuele Ammatuna Department of Biopathology, Policlinico Tor Vergata, Rome, ItalyCorrespondence[email protected]
, MD, PhD,
Chiara Sarlo Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Licia Ottaviani Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Micol Quaresima Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Francesco Buccisano Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Selenia Campagna Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Maria Ilaria Del Principe Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Gottardo De Angelis Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Lucia Anemona Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Svitlana Gumenyuk Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
,
Sergio Amadori Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
&
Adriano Venditti Department of Biopathology, Policlinico Tor Vergata, Rome, Italy
 show all
Pages 857-858 | Received 06 Nov 2008, Accepted 19 Feb 2009, Published online: 21 Jul 2009

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Satoshi Ichikawa, Noriko Fukuhara, Kei Saito, Hisayuki Yokoyama, Koichi Onodera, Yasushi Onishi, Ryo Ichinohasama & Hideo Harigae. (2020) Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab. Leukemia & Lymphoma 61:6, pages 1504-1507.
Read now

Articles from other publishers (1)

Adam Suleman, Hubert Tsui, Zeina Ghorab, Philip W. Lam & Lee Mozessohn. (2022) EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia. Annals of Hematology 102:2, pages 471-472.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.